The antitrust cop says that the more than 300 patent listings stall generic competition, keeping prices high for diabetes ...
The antitrust cop says that the more than 300 patent listings stall generic competition, keeping prices high for diabetes drugs, inhalers and more. The Federal Trade Commission is challenging ...
The Federal Trade Commission (FTC) continues slicing a machete through the patent thicket. On Tuesday, the agency sent warning ...
Federal antitrust officials have redoubled efforts to challenge what they see as improper pharma patent listings that delay the ...